Related Experiment Video
Updated: Dec 26, 2025
03:23
Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis
Published on: May 10, 2024
1.2K
Tegafur/gimeracil/oteracil-induced eosinophilic pneumonia
Toshiyuki Sumi1,2, Hisashi Nakata1, Yuji Mori1
1Department of Pulmonary Medicine Hakodate Goryoukaku Hospital Hakodate Japan.
Respirology Case Reports
|March 18, 2020
Summary
Tegafur/gimeracil/oteracil (TS-1) can cause eosinophilic pneumonia, a type of drug-induced lung injury. Awareness is crucial for clinicians managing patients on this chemotherapy regimen.
Area of Science:
- Pulmonology
- Oncology
- Pharmacology
Background:
- Drug-induced lung injury (DILI) encompasses various pulmonary reactions to medications.
- Chemotherapy agents, including combination drugs like TS-1, are known to cause DILI.
Purpose of the Study:
- To highlight eosinophilic pneumonia as a potential adverse event of tegafur/gimeracil/oteracil (TS-1).
- To increase clinician awareness of this specific DILI manifestation.
Main Methods:
- This is a statement of awareness based on clinical observation and literature.
- No specific experimental methods were employed for this summary.
Main Results:
- Eosinophilic pneumonia is identified as a specific type of drug-induced lung injury.
- Tegafur/gimeracil/oteracil (TS-1) is implicated as a causative agent.
Conclusions:
- Clinicians must consider TS-1 as a potential cause of eosinophilic pneumonia in patients presenting with relevant symptoms.
- Early recognition and management of TS-1-induced lung injury are critical for patient outcomes.
Related Concept Videos
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.6K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.6K
01:30Asthma-IV: Diagnostic and Management
3.0K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.0K
01:19Antiasthma Drugs: Leukotriene Modifiers
1.6K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.6K
01:24Asthma-III: Symptoms and Complications
3.2K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
3.2K
01:26Asthma-II: Pathophysiology and Classification
3.9K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.9K
01:24Antiasthma Drugs: Methylxanthines
1.5K
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
1.5K